Title : Celecoxib, a selective cyclooxygenase 2 inhibitor, protects against human epidermal growth factor receptor 2 (HER-2)/neu-induced breast cancer.

Pub. Date : 2002 Oct 1

PMID : 12359744






6 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Celecoxib, a selective cyclooxygenase 2 inhibitor, protects against human epidermal growth factor receptor 2 (HER-2)/neu-induced breast cancer. Celecoxib erb-b2 receptor tyrosine kinase 2 Homo sapiens
2 Celecoxib, a selective cyclooxygenase 2 inhibitor, protects against human epidermal growth factor receptor 2 (HER-2)/neu-induced breast cancer. Celecoxib erb-b2 receptor tyrosine kinase 2 Homo sapiens
3 Celecoxib, a selective cyclooxygenase 2 inhibitor, protects against human epidermal growth factor receptor 2 (HER-2)/neu-induced breast cancer. Celecoxib erb-b2 receptor tyrosine kinase 2 Homo sapiens
4 The aim of this study was to determine whether celecoxib, a selective Cox-2 inhibitor, protected against HER-2/neu-induced experimental breast cancer. Celecoxib erb-b2 receptor tyrosine kinase 2 Homo sapiens
5 The aim of this study was to determine whether celecoxib, a selective Cox-2 inhibitor, protected against HER-2/neu-induced experimental breast cancer. Celecoxib erb-b2 receptor tyrosine kinase 2 Homo sapiens
6 Treatment with celecoxib (500 ppm) significantly reduced the incidence of mammary tumors in MMTV/neu mice (P = 0.003) and caused about a 50% reduction in mammary prostaglandin E2 (PGE2) levels. Celecoxib erb-b2 receptor tyrosine kinase 2 Homo sapiens